跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AG-TADALAFIL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
AG-TADALAFIL
Authorized
STANDARD
AG-TADALAFIL
ANGITA PHARMA INC.
🇨🇦 Health Canada
Approval Date
Jul 7, 2025
Approval ID
36ca8b637b4600ae
Company
ANGITA PHARMA INC.
Type
Standard
Approval Details
Approval Id
36ca8b637b4600ae
Drug Approval Canada Name
AG-TADALAFIL
Product Name
AG-TADALAFIL
Status
Marketed
Status Date
2019-11-21
Original Market Date
2019-11-21
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
PRESCRIPTION
Ahfs
24:12.12
Atc Original
G04BE08 TADALAFIL
Aig Number
0149485002
Company Name
ANGITA PHARMA INC.
Company Address
1310 Rue Nobel Boucherville Quebec Canada J4B 5H3
Active Ingredients
TADALAFIL
20 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 7, 2025
Approval ID
36ca8b637b4600ae
Type
Standard
Back to Health Canada Approvals